Candel Therapeutics, Inc (CADL) insider trading
Every open-market stock purchase and sale by Candel Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Paul Peter Tak (CEO) and 1 other sold $3.2M in the last 90 days.
- Last insider buy: Paul B Manning (Insider), $3M, 7 months ago.
Last 12 months: insiders bought $3M (1 buy) and sold $3.6M (4 sales). Last close $10.54 on Sep 11, 2026.
Recent CADL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 11, 2026 | Paul Peter Tak (CEO) | Sold | $621K |
| Sep 10, 2026 | Paul Peter Tak (CEO) | Sold | $2.5M |
| Sep 10, 2026 | Paul Peter Tak (CEO) | Bought (not open market) | — |
| Aug 17, 2026 | Seshu Tyagarajan (CTO) | Sold | $84K |
| Jul 6, 2026 | Mark E. Sims (C-suite exec) | Bought (not open market) | — |
| Jun 30, 2026 | Paul B Manning (Insider) | Bought (not open market) | $19K |
| Jun 30, 2026 | Joseph C Papa (Insider) | Bought (not open market) | $11.5K |
| Jun 30, 2026 | Nicoletta Loggia (Insider) | Bought (not open market) | $3.3K |
| Jun 29, 2026 | Francesca Barone (C-suite exec) | Sold | $236K |
| Jun 29, 2026 | Seshu Tyagarajan (CTO) | Sold | $70.2K |
| Jun 23, 2026 | Joseph C Papa (Insider) | Bought (not open market) | — |
| Jun 23, 2026 | Paul B Manning (Insider) | Bought (not open market) | — |
| Jun 23, 2026 | Edward J. Benz JR (Insider) | Bought (not open market) | — |
| Jun 23, 2026 | Renee Gaeta (Insider) | Bought (not open market) | — |
| Jun 23, 2026 | Maha Radhakrishnan (Insider) | Bought (not open market) | — |
| Jun 23, 2026 | Christopher Martell (Insider) | Bought (not open market) | — |
| Jun 23, 2026 | Gary J. Nabel (Insider) | Bought (not open market) | — |
| Jun 23, 2026 | Nicoletta Loggia (Insider) | Bought (not open market) | — |
| Jun 23, 2026 | Diem Nguyen (Insider) | Bought (not open market) | — |
| Mar 31, 2026 | Paul B Manning (Insider) | Bought (not open market) | $19K |
| Mar 31, 2026 | Joseph C Papa (Insider) | Bought (not open market) | $11.5K |
| Mar 31, 2026 | Nicoletta Loggia (Insider) | Bought (not open market) | $3.2K |
| Feb 23, 2026 | Paul B Manning (Insider) | Bought | $3M |
| Jan 26, 2026 | Charles Schoch (CFO) | Bought (not open market) | — |
| Jan 26, 2026 | Seshu Tyagarajan (CTO) | Bought (not open market) | — |
Who's trading CADL
- Paul Peter Tak, CEO: sold $3.2M (2 sales), last Sep 11, 2026
- Seshu Tyagarajan, CTO: sold $154K (2 sales), last Aug 17, 2026
- Mark E. Sims, C-suite exec: other filings, last Jul 6, 2026
- Joseph C Papa, Insider: other filings, last Jun 30, 2026
- Nicoletta Loggia, Insider: other filings, last Jun 30, 2026
- Paul B Manning, Insider: bought $3M (1 buy), last Jun 30, 2026
- Francesca Barone, C-suite exec: sold $236K (1 sale), last Jun 29, 2026
- Gary J. Nabel, Insider: other filings, last Jun 23, 2026
- Edward J. Benz JR, Insider: other filings, last Jun 23, 2026
- Renee Gaeta, Insider: other filings, last Jun 23, 2026
- Christopher Martell, Insider: other filings, last Jun 23, 2026
- Diem Nguyen, Insider: other filings, last Jun 23, 2026
- Maha Radhakrishnan, Insider: other filings, last Jun 23, 2026
- Charles Schoch, Insider: other filings, last Jan 26, 2026
- William Garrett Nichols, C-suite exec: other filings, last Jan 26, 2026
Get free alerts when an insider at Candel Therapeutics, Inc files a new trade →